Sign up
Log in
12 Health Care Stocks Moving In Tuesday's After-Market Session
Share
Listen to the news

Gainers

  • Sonoma Pharmaceuticals (NASDAQ:SNOA) stock moved upwards by 63.1% to $3.8 during Tuesday's after-market session. The company's market cap stands at $6.1 million.
  • ENDRA Life Sciences (NASDAQ:NDRA) stock moved upwards by 44.04% to $4.47. The company's market cap stands at $2.3 million.
  • Renovaro (NASDAQ:RENB) stock increased by 11.37% to $0.39. The market value of their outstanding shares is at $61.5 million.
  • Serina Therapeutics (AMEX:SER) stock rose 9.09% to $6.0. The market value of their outstanding shares is at $59.5 million.
  • Lixte Biotechnology (NASDAQ:LIXT) shares increased by 7.96% to $1.22. The company's market cap stands at $3.2 million.
  • NewAmsterdam Pharma Co (NASDAQ:NAMS) stock increased by 7.2% to $18.0. The market value of their outstanding shares is at $1.9 billion.

Losers

  • Vincerx Pharma (NASDAQ:VINC) shares decreased by 41.5% to $0.06 during Tuesday's after-market session.
  • Akari Therapeutics (NASDAQ:AKTX) stock declined by 22.63% to $1.06. The company's market cap stands at $30.6 million. The company's, Q4 earnings came out 4 days ago.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock decreased by 14.43% to $1.78. The market value of their outstanding shares is at $24.4 million.
  • Know Labs (AMEX:KNW) stock fell 9.31% to $0.39. The company's market cap stands at $1.0 million.
  • Gelteq (NASDAQ:GELS) shares declined by 9.06% to $2.61. The company's market cap stands at $24.6 million.
  • Titan Pharma (NASDAQ:TTNP) shares fell 8.98% to $3.32. The company's market cap stands at $3.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.